| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M209548200 |
| P8608 | Fatcat ID | release_rhkiad2gmvacxcslmkfbnnceim |
| P698 | PubMed publication ID | 12411431 |
| P5875 | ResearchGate publication ID | 11054380 |
| P50 | author | Jean-Philippe Richard | Q39387707 |
| Leonid V Chernomordik | Q115262356 | ||
| Kamran Melikov | Q115262433 | ||
| P2093 | author name string | Bernard Lebleu | |
| Corinne Ramos | |||
| Eric Vives | |||
| Birgit Verbeure | |||
| Mike J Gait | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 585-590 | |
| P577 | publication date | 2002-10-30 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | |
| P478 | volume | 278 |
| Q35169682 | "Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms |
| Q89432319 | (Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling |
| Q24681544 | 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase |
| Q38751257 | A Biotin Ligase-Based Assay for the Quantification of the Cytosolic Delivery of Therapeutic Proteins |
| Q28533791 | A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells |
| Q39638812 | A Cationic TAT Peptide Inhibits Herpes Simplex Virus Type 1 Infection of Human Corneal Epithelial Cells |
| Q35888154 | A Cell Internalizing Antibody Targeting Capsid Protein (p24) Inhibits the Replication of HIV-1 in T Cells Lines and PBMCs: A Proof of Concept Study |
| Q57369907 | A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids |
| Q33213902 | A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells |
| Q39277953 | A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity |
| Q33326188 | A cell-penetrating helical peptide as a potential HIV-1 inhibitor |
| Q31151264 | A cobaltocenium-peptide bioconjugate shows enhanced cellular uptake and directed nuclear delivery. |
| Q50799073 | A critical period requiring Rho proteins for cell cycle progression uncovered by reversible protein transduction in endothelial cells |
| Q33220250 | A critical reassessment of penetratin translocation across lipid membranes |
| Q42813230 | A gene delivery system based on the N-terminal domain of human topoisomerase I |
| Q33215569 | A high-throughput assay for assessing the cell permeability of combinatorial libraries |
| Q39558788 | A modified Tat peptide for selective intracellular delivery of macromolecules |
| Q39197445 | A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs |
| Q33712960 | A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells |
| Q35804697 | A non-covalent peptide-based carrier for in vivo delivery of DNA mimics |
| Q50032346 | A novel CAV derived cell-penetrating peptide efficiently delivers exogenous molecules through caveolae-mediated endocytosis |
| Q42922886 | A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1 |
| Q40290076 | A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium |
| Q39124266 | A polymeric domain that promotes cellular internalization |
| Q42861975 | A practical approach for intracellular protein delivery |
| Q90720927 | A review of lipidation in the development of advanced protein and peptide therapeutics |
| Q33251930 | A targeted protease substrate for a quantitative determination of protease activities in the endolysosomal pathway |
| Q34031434 | A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis |
| Q57362598 | A ubiquitin-based assay for the cytosolic uptake of protein transduction domains |
| Q35853264 | AU4S: a novel synthetic peptide to measure the activity of ATG4 in living cells |
| Q92071340 | Abiotic Factors Promote Cell Penetrating Peptide Permeability in Enterobacteriaceae Models |
| Q24537504 | Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix |
| Q37405251 | Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide. |
| Q42138358 | Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain |
| Q39310299 | Altering the Tat-derived peptide bioactivity landscape by changing the arginine side chain length. |
| Q35953315 | Aminopeptidase P Mediated Targeting for Breast Tissue Specific Conjugate Delivery. |
| Q50905802 | Amphiphilic Lipopeptide-Mediated Transport of Insulin and Cell Membrane Penetration Mechanism. |
| Q38973145 | Amphiphilic bicyclic peptides as cellular delivery agents |
| Q42105272 | An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging |
| Q39625484 | Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells |
| Q34725033 | Analysis of protein kinase A activity in insulin-secreting cells using a cell-penetrating protein substrate and capillary electrophoresis |
| Q47448961 | Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. |
| Q36086779 | Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome |
| Q24816124 | Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides |
| Q26738467 | Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm? |
| Q55235234 | Antigen B from Echinococcus granulosus enters mammalian cells by endocytic pathways. |
| Q37845172 | Antimicrobial peptides with cell-penetrating peptide properties and vice versa |
| Q29547675 | Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? |
| Q26769800 | Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos |
| Q38166533 | Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. |
| Q41500169 | Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the Cytoplasm |
| Q37635334 | Arginine-rich cell-penetrating peptides. |
| Q37373439 | Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides |
| Q35690370 | Arginine-rich polyplexes for gene delivery to neuronal cells |
| Q40182984 | Assessing the delivery efficacy and internalization route of cell-penetrating peptides |
| Q42722252 | Asymmetric insertion of membrane proteins in lipid bilayers by solid-state NMR paramagnetic relaxation enhancement: a cell-penetrating Peptide example |
| Q38833059 | Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues. |
| Q41380434 | Autonomously folded α-helical lockers promote RNAi |
| Q46456003 | Bacterial cell penetration by beta3-oligohomoarginines: indications for passive transfer through the lipid bilayer |
| Q40368660 | Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens. |
| Q34080613 | Beta-peptides with improved affinity for hDM2 and hDMX. |
| Q36481540 | Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds |
| Q40662783 | Bio-effectiveness of Tat-catalase conjugate: a potential tool for the identification of H2O2-dependent cellular signal transduction pathways |
| Q34343478 | BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies |
| Q38722141 | Bioactive clusters promoting cell penetration and nucleic acid complexation for drug and gene delivery applications: from designed to self-assembled and responsive systems. |
| Q36904010 | Biodegradable nanoparticles for cytosolic delivery of therapeutics |
| Q36492687 | Biological activity and biotechnological aspects of peptide nucleic acid. |
| Q37969514 | Biological activity of ruthenium nitrosyl complexes |
| Q35565919 | Biological applications of protein transduction technology |
| Q39804384 | Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite |
| Q52365070 | Biophysical characterisation of the recombinant human frataxin precursor. |
| Q42979619 | Bioportide: an emergent concept of bioactive cell-penetrating peptides |
| Q38120721 | Bioportides: Bioactive cell‐penetrating peptides that modulate cellular dynamics |
| Q42240132 | Block copolymers containing a hydrophobic domain of membrane-lytic peptides form micellar structures and are effective gene delivery agents |
| Q45859186 | Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells |
| Q36299512 | Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides |
| Q42255378 | Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem. |
| Q61799189 | CGA-N9, an antimicrobial peptide derived from chromogranin A: direct cell penetration of and endocytosis by |
| Q34013526 | CNS delivery via adsorptive transcytosis |
| Q28079386 | CPP-Assisted Intracellular Drug Delivery, What Is Next? |
| Q39485838 | CXCR4(+)-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis. |
| Q44957969 | Calcitonin-derived carrier peptide plays a major role in the membrane localization of a peptide-cargo complex |
| Q35691164 | Cancer cell surface induced peptide folding allows intracellular translocation of drug |
| Q39252765 | Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study |
| Q38495028 | Cationic cell-penetrating peptides as vehicles for siRNA delivery |
| Q26830018 | Cationic membrane peptides: atomic-level insight of structure-activity relationships from solid-state NMR |
| Q44541953 | Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time |
| Q51334188 | Cell Entry of C3 Exoenzyme from Clostridium botulinum |
| Q47547640 | Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. |
| Q35952119 | Cell Permeable Cocaine Esterases Constructed by Chemical Conjugation and Genetic Recombination |
| Q42117504 | Cell entry of arginine-rich peptides is independent of endocytosis |
| Q39629419 | Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid |
| Q37755594 | Cell penetrating elastin-like polypeptides for therapeutic peptide delivery |
| Q37013966 | Cell penetrating peptide conjugates of steric block oligonucleotides |
| Q34289086 | Cell penetrating peptide inhibitors of nuclear factor-kappa B. |
| Q38472405 | Cell penetrating peptides can exert biological activity: a review |
| Q35740453 | Cell penetrating peptides in drug delivery |
| Q37577592 | Cell penetrating peptides: how do they do it? |
| Q36795351 | Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives |
| Q37629659 | Cell penetrating peptides: overview and applications to the delivery of oligonucleotides |
| Q51835694 | Cell surface adherence and endocytosis of protein transduction domains |
| Q34572746 | Cell surface binding and internalization of aβ modulated by degree of aggregation |
| Q57291698 | Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment |
| Q38622635 | Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals |
| Q55638503 | Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics. |
| Q38974236 | Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems. |
| Q33664417 | Cell-Penetrating Peptides: A Comparative Study on Lipid Affinity and Cargo Delivery Properties |
| Q47586545 | Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity |
| Q35123792 | Cell-free production of transducible transcription factors for nuclear reprogramming. |
| Q42739622 | Cell-penetrating HIV1 TAT peptides can generate pores in model membranes |
| Q85042304 | Cell-penetrating hollow spheres based on milk protein |
| Q37295720 | Cell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia-reperfusion injury in rats |
| Q40808308 | Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus. |
| Q24814987 | Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells |
| Q34093606 | Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea |
| Q47218405 | Cell-penetrating peptide-driven Cre recombination in porcine primary cells and generation of marker-free pigs. |
| Q36586917 | Cell-penetrating peptides and antimicrobial peptides: how different are they? |
| Q37140660 | Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease |
| Q38881439 | Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals |
| Q27481059 | Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity |
| Q42029912 | Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers. |
| Q37039034 | Cell-penetrating peptides for drug delivery across membrane barriers |
| Q83728225 | Cell-penetrating peptides modulate the vascular action of phenylephrine |
| Q36824518 | Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications |
| Q37594526 | Cell-penetrating peptides: achievements and challenges in application for cancer treatment |
| Q26800100 | Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo |
| Q37975420 | Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide |
| Q34373522 | Cell-permeable beta-peptide inhibitors of p53/hDM2 complexation |
| Q36272601 | Cell-specific targeting of lipid-based carriers for ODN and DNA. |
| Q39502685 | Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis |
| Q37668316 | Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents |
| Q34718191 | Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization |
| Q48798795 | Cellular Antisense Activity of PNA-Oligo(bicycloguanidinium) Conjugates Forming Self-Assembled Nanoaggregates |
| Q39576002 | Cellular Trafficking and Photochemical Internalization of Cell Penetrating Peptide Linked Cargo Proteins: A Dual Fluorescent Labeling Study |
| Q39152111 | Cellular Uptake Mechanism and Therapeutic Utility of a Novel Peptide in Targeted-Delivery of Proteins into Neuronal Cells |
| Q49359922 | Cellular Uptake of A Taurine-Modified, Ester Bond-Decorated D-Peptide Derivative via Dynamin-Based Endocytosis and Macropinocytosis |
| Q37850458 | Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis |
| Q33265007 | Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect |
| Q41942565 | Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6. |
| Q31050606 | Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). |
| Q38513888 | Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction |
| Q36837220 | Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation site |
| Q39937425 | Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells |
| Q38812110 | Cellular uptake of a cystine-knot peptide and modulation of its intracellular trafficking. |
| Q43502847 | Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement |
| Q38740325 | Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways. |
| Q40432261 | Cellular uptake of the EBV transcription factor EB1/Zta. |
| Q35549411 | Cellular utake of the Tat peptide: an endocytosis mechanism following ionic interactions |
| Q38626721 | Challenges in carrier-mediated intracellular delivery: moving beyond endosomal barriers. |
| Q35049077 | Characterisation of cell-penetrating peptide-mediated peptide delivery |
| Q33305075 | Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein |
| Q39964130 | Characterization of endocytic uptake of MK2-inhibitor peptides |
| Q34476428 | Characterizing the localized surface plasmon resonance behaviors of Au nanorings and tracking their diffusion in bio-tissue with optical coherence tomography. |
| Q28535219 | Chemical-functional diversity in cell-penetrating peptides |
| Q53275847 | Chemo-Enzymatic Synthesis of Linear and Branched Cationic Peptides: Evaluation as Gene Carriers |
| Q35707896 | Chlorogenic Acid Improves Neuroprotective Effect of PEP-1-Ribosomal Protein S3 Against Ischemic Insult |
| Q83963455 | Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma |
| Q35012357 | Chromatin structure exhibits spatio-temporal heterogeneity within the cell nucleus |
| Q43203322 | Coexistence of a two-states organization for a cell-penetrating peptide in lipid bilayer |
| Q84970385 | Combination Self‐Assembly of β‐Sheet Peptides and Carbon Nanotubes: Functionalizing Carbon Nanotubes with Bioactive β‐Sheet Block Copolypeptides |
| Q61797303 | Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review |
| Q45872650 | Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression. |
| Q33320806 | Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells |
| Q41585561 | Comparative study of guanidine-based and lysine-based brush copolymers for plasmid delivery |
| Q46500463 | Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. |
| Q36510057 | Comparative study on transduction and toxicity of protein transduction domains. |
| Q39616052 | Comparison of electroporation and Chariot™ for delivery of β-galactosidase into mammalian cells: strategies to use trehalose in cell preservation |
| Q44051673 | Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. |
| Q52625902 | Concentration-dependent mechanisms of cell penetration and killing by the de novo designed antifungal hexapeptide PAF26. |
| Q40246552 | Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy |
| Q52568387 | Construction and Evaluation of the Tumor-Targeting, Cell-Penetrating Multifunctional Molecular Probe iCREKA. |
| Q39558825 | Contributions of Glycosaminoglycan Binding and Clustering to the Biological Uptake of the Nonamphipathic Cell-Penetrating Peptide WR9 |
| Q37813021 | Controlling Subcellular Delivery to Optimize Therapeutic Effect |
| Q47810720 | Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP. |
| Q90460439 | Cooperative Cellular Uptake and Activity of Octaarginine Antisense Peptide Nucleic acid (PNA) Conjugates |
| Q50442970 | Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability |
| Q33732116 | Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines |
| Q51797571 | Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. |
| Q44601156 | Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. |
| Q38814443 | D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics. |
| Q36982986 | Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. |
| Q34223983 | Delivery of antibodies to the cytosol: debunking the myths |
| Q28542002 | Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9 |
| Q37363141 | Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. |
| Q36972120 | Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies. |
| Q38369597 | Delivery of therapeutic oligonucleotides with cell penetrating peptides. |
| Q38974213 | Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides |
| Q58618196 | Design of a novel cell-permeable chimeric peptide to promote wound healing |
| Q39583280 | Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E). |
| Q30493051 | Determination of penetratin secondary structure in live cells with Raman microscopy |
| Q39145426 | Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. |
| Q92703678 | Development of Organelle Replacement Therapy Using a Stearyl-Polyhistidine Peptide against Lysosomal Storage Disease Cells |
| Q38856371 | Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes. |
| Q51747757 | Development of a cell permeable competitive antagonist of RhoA and CRMP4 binding, TAT-C4RIP, to promote neurite outgrowth |
| Q38413685 | Development of protein mimics for intracellular delivery |
| Q51196223 | Different oligoarginine modifications alter endocytic pathways and subcellular trafficking of polymeric nanoparticles. |
| Q42723857 | Differential intracellular distribution of DNA complexed with polyethylenimine (PEI) and PEI-polyarginine PTD influences exogenous gene expression within live COS-7 cells |
| Q33276598 | Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases |
| Q34819513 | Dimerization of 30Kc19 protein in the presence of amphiphilic moiety and importance of Cys-57 during cell penetration. |
| Q30543833 | Direct Delivery of Functional Proteins and Enzymes to the Cytosol Using Nanoparticle-Stabilized Nanocapsules |
| Q53113603 | Direct Quantification of PTD Transduction Using Real-Time Monitoring |
| Q84754858 | Direct Quantitation of Peptide-Mediated Protein Transport across a Droplet–Interface Bilayer |
| Q40504496 | Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase. |
| Q45154162 | Direct observation of anion-mediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes |
| Q37240232 | Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine |
| Q28477376 | Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles |
| Q28829292 | Discovery and characterization of smORF-encoded bioactive polypeptides |
| Q35625290 | Discovery of Peptide ligands for hepatic stellate cells using phage display |
| Q39489932 | Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells |
| Q81131655 | Disulfide conjugation of peptides to oligonucleotides and their analogs |
| Q30855871 | Diversity-Oriented Stapling Yields Intrinsically Cell-Penetrant Inducers of Autophagy. |
| Q34432312 | Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery |
| Q83357754 | Dynamics of transportan in bicelles is surface charge dependent |
| Q47761388 | Effect of Cell Permeable Peptide of c-Jun NH2-Terminal Kinase Inhibitor on the Attenuation of Renal Ischemia-Reperfusion Injury in Pigs |
| Q50218239 | Effect of a Flexible Linker on Recombinant Expression of Cell-Penetrating Peptide Fusion Proteins and Their Translocation into Fungal Cells. |
| Q51047522 | Effect of arginine-rich cell penetrating peptides on membrane pore formation and life-times: a molecular simulation study |
| Q50612461 | Effect of crotamine, a cell-penetrating peptide, on blastocyst production and gene expression of in vitro fertilized bovine embryos |
| Q36837673 | Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin |
| Q51042734 | Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative |
| Q43419167 | Effects of the TAT Peptide Orientation and Relative Location on the Protein Transduction Efficiency |
| Q34149828 | Efficient and targeted delivery of siRNA in vivo |
| Q37328068 | Efficient siRNA delivery with non-viral polymeric vehicles |
| Q38300633 | Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide |
| Q35679874 | Electrochemical impedimetric biosensor based on a nanostructured polycarbonate substrate |
| Q42256218 | Elevation of protein kinase Cα stimulates osteogenic differentiation of mesenchymal stem cells through the TAT-mediated protein transduction system |
| Q41998121 | Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticles. |
| Q88611552 | Emerging Methods and Design Principles for Cell-Penetrant Peptides |
| Q40199589 | Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide. |
| Q38626954 | Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans |
| Q59286596 | Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1 |
| Q37957323 | Engineered biological entities for drug delivery and gene therapy protein nanoparticles. |
| Q98612778 | Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue |
| Q24797478 | Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells |
| Q38963387 | Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1. |
| Q34089281 | Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization |
| Q39965322 | Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. |
| Q53646238 | Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG. |
| Q48092003 | Enhanced purification of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells |
| Q35087556 | Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides |
| Q45011121 | Enhancing membrane permeability by fatty acylation of oligoarginine peptides |
| Q39274701 | Enhancing the Cellular Delivery of Nanoparticles using Lipo-Oligoarginine Peptides |
| Q37043911 | Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides |
| Q34056922 | Enlarging the scope of cell-penetrating prenylated peptides to include farnesylated 'CAAX' box sequences and diverse cell types |
| Q40468131 | Evaluating the Delivery of Proteins to the Cytosol of Mammalian Cells. |
| Q42823027 | Evaluation of Cell-Penetrating Peptide/Adenovirus Particles for Transduction of CAR-Negative Cells |
| Q47801933 | Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. |
| Q29048586 | Evaluation of the use of therapeutic peptides for cancer treatment |
| Q40181528 | Evidence for intercellular trafficking of VP22 in living cells |
| Q52551292 | Evidence in support of signaling endosome-based retrograde survival of sympathetic neurons |
| Q42168186 | Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo |
| Q46516001 | Evidence that membrane transduction of oligoarginine does not require vesicle formation |
| Q30497908 | Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization. |
| Q52715623 | Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes |
| Q28480614 | Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase |
| Q34998244 | Exogenous and Cell Surface Glycosaminoglycans Alter DNA Delivery Efficiency of Arginine and Lysine Homopeptides in Distinctly Different Ways |
| Q37988482 | Exploring Transduction Mechanisms of Protein Transduction Domains (PTDs) in Living Cells Utilizing Single-Quantum Dot Tracking (SQT) Technology |
| Q33866011 | Exploring the cellular accumulation of metal complexes |
| Q39616924 | Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity. |
| Q36082666 | Exquisitely specific bisubstrate inhibitors of c-Src kinase. |
| Q41913898 | Factors controlling the efficiency of Tat-mediated plasmid DNA transfer |
| Q35111049 | Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: involvement of internalization in the in vivo role of exogenous FGF12. |
| Q110651387 | Five Silkworm 30K Proteins Are Involved in the Cellular Immunity against Fungi |
| Q58564633 | Fluorescence Correlation Spectroscopy Reveals Efficient Cytosolic Delivery of Protein Cargo by Cell-Permeant Miniature Proteins |
| Q92947788 | Fluorescent Tau-derived Peptide for Monitoring Microtubules in Living Cells |
| Q36900822 | Fluorogenic probe for constitutive cellular endocytosis |
| Q84044756 | Formation of Tat-TAR containing ribonucleoprotein complexes for biochemical and structural analyses |
| Q36554270 | Free Energy of Translocating an Arginine-Rich Cell-Penetrating Peptide across a Lipid Bilayer Suggests Pore Formation |
| Q27318180 | Functional characterisation of the WW minimal domain for delivering therapeutic proteins by adenovirus dodecahedron |
| Q39381101 | Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. |
| Q37302292 | Functional inclusion bodies produced in the yeast Pichia pastoris. |
| Q38928987 | Functional peptides for siRNA delivery |
| Q31137535 | Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells |
| Q61013237 | Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability |
| Q37772516 | Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. |
| Q45020310 | GeT peptides: a single-domain approach to gene delivery |
| Q33904910 | Gene delivery from supercharged coiled-coil protein and cationic lipid hybrid complex |
| Q34016744 | Gene knockdowns in adult animals: PPMOs and vivo-morpholinos |
| Q99403216 | General Method for Peptide Recognition in Water through Bioinspired Complementarity |
| Q52608554 | Genetic Engineering of Crypthecodinium cohnii to Increase Growth and Lipid Accumulation |
| Q42816669 | Genetic engineering of mammalian cells by direct delivery of FLP recombinase protein |
| Q40063020 | Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy |
| Q38307864 | Getting across the cell membrane: an overview for small molecules, peptides, and proteins |
| Q46786462 | Glycosphingolipid-facilitated membrane insertion and internalization of cobra cardiotoxin. The sulfatide.cardiotoxin complex structure in a membrane-like environment suggests a lipid-dependent cell-penetrating mechanism for membrane binding polypept |
| Q39973491 | Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies. |
| Q30472806 | Gold nanoparticles delivery in mammalian live cells: a critical review |
| Q51420709 | Golden perspective: application of laser-generated gold nanoparticle conjugates in reproductive biology. |
| Q39706590 | Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis |
| Q30479486 | Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation |
| Q47583201 | Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer. |
| Q37784410 | HIV TAT Protein Transduction Domain Mediated Cell Binding and Intracellular Delivery of Nanoparticles |
| Q24564896 | HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses |
| Q48797704 | Happy birthday cell penetrating peptides: Already 20 years |
| Q40644955 | Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. |
| Q35084374 | Heparan sulfate proteoglycan as a plasma membrane carrier |
| Q39440362 | Hepatitis B virus envelope L protein-derived bio-nanocapsules: Mechanisms of cellular attachment and entry into human hepatic cells |
| Q33554640 | Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells |
| Q42807401 | High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. |
| Q34533160 | High-glucose-induced endothelial cell injury is inhibited by a Peptide derived from human apolipoprotein E. |
| Q42813621 | Highly efficient intracellular drug delivery with a negatively charged hyperbranched polysulfonamine |
| Q33285497 | How to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo (Review). |
| Q27355524 | How to unveil self-quenched fluorophores and subsequently map the subcellular distribution of exogenous peptides |
| Q45873436 | Human cytomegalovirus protein pp65: an efficient protein carrier system into human dendritic cells |
| Q34520408 | Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck |
| Q42359281 | Hydroxylated Fluorescent Dyes for Live-Cell Labeling: Synthesis, Spectra and Super-Resolution STED. |
| Q34004482 | Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides |
| Q33393157 | Identification and characterization of a novel cell-penetrating peptide |
| Q30564015 | Identification of a Novel Cell-Penetrating Peptide from Human Phosphatidate Phosphatase LpIN3 |
| Q36010308 | Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity |
| Q43559547 | Imaging the cytosolic drug delivery mechanism of HDL-like nanoparticles. |
| Q58696260 | Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope |
| Q39751992 | Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells |
| Q46976778 | Impact of the guanidinium group on hybridization and cellular uptake of cationic oligonucleotides |
| Q34021802 | Imperatoxin A, a Cell-Penetrating Peptide from Scorpion Venom, as a Probe of Ca-Release Channels/Ryanodine Receptors |
| Q49852449 | Importance of phosphoinositide binding by human β-defensin 3 for Akt-dependent cytokine induction |
| Q36972091 | Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. |
| Q37277330 | Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges |
| Q39605996 | In Vivo Anti-Tumor Effect of Expressing p14ARF-TAT Using a FGF2-Targeted Cationic Lipid Vector |
| Q34996432 | In vitro and ex vivo evaluation of smart infra-red fluorescent caspase-3 probes for molecular imaging of cardiovascular apoptosis |
| Q44090492 | Increased Hydrophobic Block Length of PTDMs Promotes Protein Internalization |
| Q64118404 | Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide |
| Q28478188 | Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Peptide that Binds the Tat-Transactivating Response Element (TAR) RNA |
| Q42143723 | Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide |
| Q44658031 | Inhibition of excitatory neuronal cell death by cell‐permeable calcineurin autoinhibitory peptide |
| Q24324220 | Inhibition of mitochondrial neural cell death pathways by protein transduction of Bcl-2 family proteins |
| Q33513277 | Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60). |
| Q35031898 | Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells |
| Q38563691 | Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions |
| Q40477356 | Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. |
| Q33577349 | Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers |
| Q42013682 | Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization |
| Q42239679 | Interference with RUNX1/ETO Leukemogenic Function by Cell-Penetrating Peptides Targeting the NHR2 Oligomerization Domain |
| Q92900087 | Internalization mechanisms of cell-penetrating peptides |
| Q45265202 | Internalization of Jembrana disease virus Tat: possible pathway and implication |
| Q24655939 | Internalization of cationic peptides: the road less (or more?) traveled |
| Q26795943 | Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies |
| Q26767093 | Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease |
| Q39515403 | Intracellular Protein Target Detection by Quantum Dots Optimized for Live Cell Imaging |
| Q37291277 | Intracellular Trafficking Network of Protein Nanocapsules: Endocytosis, Exocytosis and Autophagy |
| Q42835108 | Intracellular delivery of antibodies using TAT fusion protein A |
| Q40560822 | Intracellular delivery of functional proteins via decoration with transporter peptides |
| Q37176400 | Intracellular delivery of nanoparticles via the HIV-1 tat peptide |
| Q33321966 | Intracellular delivery of peptides via association with ubiquitin or SUMO-1 coupled to protein transduction domains |
| Q45478176 | Intracellular route and biological activity of exogenously delivered Rep proteins from the adeno-associated virus type 2. |
| Q26740106 | Intracellular targeting with engineered proteins |
| Q37710990 | Intracellular transduction using cell-penetrating peptides |
| Q42094009 | Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility |
| Q38927932 | Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide |
| Q34185626 | Investigating the intercellular spreading properties of the foamy virus Gag protein |
| Q37490599 | Labeling proteins inside living cells using external fluorophores for microscopy |
| Q90375954 | Library screening of cell-penetrating peptide for BY-2 cells, leaves of Arabidopsis, tobacco, tomato, poplar, and rice callus |
| Q38363543 | Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling. |
| Q42868352 | Lipo-oligoarginines as effective delivery vectors to promote cellular uptake |
| Q39470273 | Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration |
| Q37052581 | Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. |
| Q55145552 | Machine Learning To Predict Cell-Penetrating Peptides for Antisense Delivery. |
| Q36309720 | Macrocycles as protein-protein interaction inhibitors |
| Q36924383 | Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides |
| Q38823975 | Mapping Optimal Charge Density and Length of ROMP-Based PTDMs for siRNA Internalization |
| Q49842808 | Matrix Metalloproteinase-9-Responsive Nanogels for Proximal Surface Conversion and Activated Cellular Uptake. |
| Q39549246 | Matrix metalloproteinase-1 induces cleavage of exogenous alphaB-crystallin transduced by a cell-penetrating peptide |
| Q36503914 | Mechanism Matters: A Taxonomy of Cell Penetrating Peptides. |
| Q39834242 | Mechanism for HIV-1 Tat insertion into the endosome membrane |
| Q38385016 | Mechanism of Enhanced Cellular Uptake and Cytosolic Retention of MK2 Inhibitory Peptide Nano-polyplexes |
| Q52890143 | Mechanism of antifungal activity of antimicrobial peptide APP, a cell-penetrating peptide derivative, against Candida albicans: intracellular DNA binding and cell cycle arrest |
| Q31048762 | Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation. |
| Q40354335 | Mechanism of uptake of C105Y, a novel cell-penetrating peptide |
| Q21296784 | Mechanisms of cellular uptake of cell-penetrating peptides |
| Q37268062 | Mechanisms of peptide amphiphile internalization by SJSA-1 cells in vitro |
| Q47734666 | Mechanistic Study of the Uptake/Permeation of Cell-Penetrating Peptides Across a Caco-2 Monolayer and Their Stimulatory Effect on Epithelial Insulin Transport |
| Q42808621 | Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. |
| Q36870151 | Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery |
| Q36553868 | Melittin-grafted HPMA-oligolysine based copolymers for gene delivery |
| Q36023033 | Membrane damage as first and DNA as the secondary target for anti-candidal activity of antimicrobial peptide P7 derived from cell-penetrating peptide ppTG20 against Candida albicans |
| Q35549408 | Membrane permeability commonly shared among arginine‐rich peptides |
| Q40369050 | Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides |
| Q39986995 | Membrane transducing activity of recombinant Hoxc8 protein and its possible application as a gene delivery vector |
| Q30881434 | Membrane translocation of penetratin and its derivatives in different cell lines |
| Q33347477 | Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures |
| Q31078024 | Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58) |
| Q38122609 | Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia/reperfusion injury |
| Q38369494 | Modifications of natural peptides for nanoparticle and drug design |
| Q42122403 | Modulation of muscle contraction by a cell-permeable peptide |
| Q33677435 | Molecular basis for nanoscopic membrane curvature generation from quantum mechanical models and synthetic transporter sequences |
| Q37649485 | Molecular basis for the autonomous promotion of cell proliferation by angiogenin |
| Q40064048 | Molecular basis of the internalization of bovine immunodeficiency virus Tat protein |
| Q37985658 | Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use |
| Q36055526 | Molecular mechanisms in the dramatic enhancement of HIV‐1 Tat transduction by cationic liposomes |
| Q35997331 | Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore |
| Q44846478 | Multicolor Electron Microscopy for Simultaneous Visualization of Multiple Molecular Species |
| Q35568452 | Multifunctional gold nanorods for selective plasmonic photothermal therapy in pancreatic cancer cells using ultra-short pulse near-infrared laser irradiation. |
| Q37415239 | Multifunctional prenylated peptides for live cell analysis |
| Q35155406 | Multifunctional surface modification of gold-stabilized nanoparticles by bioorthogonal reactions |
| Q39760981 | Multimodal cell imaging by ruthenium polypyridyl labelled cell penetrating peptides. |
| Q30474384 | Multiscale observation of biological interactions of nanocarriers: from nano to macro |
| Q36692522 | Myristoyl-based transport of peptides into living cells |
| Q40037129 | N terminus of calpain 1 is a mitochondrial targeting sequence |
| Q38807254 | NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring |
| Q44922021 | NMR solution structure and position of transportan in neutral phospholipid bicelles. |
| Q81509545 | Nanobiology: particles slip cell security |
| Q42802733 | Nanoengineering of stimuli-responsive protein-based biomimetic protocells as versatile drug delivery tools |
| Q38165639 | Nanopreparations for organelle-specific delivery in cancer |
| Q37058812 | Nanovehicular intracellular delivery systems |
| Q40531370 | New transport peptides broaden the horizon of applications for peptidic pharmaceuticals. |
| Q42283138 | Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy |
| Q38084736 | Noninvasive Insulin Delivery: the Great Potential of cell-penetrating Peptides |
| Q39429345 | Novel Cell‐Penetrating Peptides Based on α‐Aminoxy Acids |
| Q40429544 | Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules |
| Q37644875 | Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma |
| Q43232047 | Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury |
| Q36512557 | Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells. |
| Q51421234 | Novel tubulin-targeted cell penetrating antimitotic octapeptide. |
| Q36120101 | Nuclear localization of HBD-1 in human keratinocytes |
| Q84758878 | OPA quantification of amino groups at the surface of Lipidic NanoCapsules (LNCs) for ligand coupling improvement |
| Q38097313 | Observing the translocation of a mitochondria-penetrating peptide with solid-state NMR |
| Q42811827 | Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. |
| Q37564527 | Oligoarginine-PEG-lipid particles for gene delivery |
| Q53643889 | Oligonucleotides make sensible strides |
| Q37393524 | Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization. |
| Q41879197 | On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide |
| Q96345373 | Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells |
| Q37975835 | Oral biodrug delivery using cell-penetrating peptide |
| Q39377152 | PEP‐1‐heat shock protein 27 protects from neuronal damage in cells and in a Parkinson’s disease mouse model |
| Q79741695 | PNA Technology |
| Q36860956 | Passive water-lipid peptide translocators with conformational switches: from single-molecule probe to cellular assay |
| Q33644922 | Pathway for polyarginine entry into mammalian cells |
| Q28577193 | Pdx-1 or Pdx-1-VP16 protein transduction induces beta-cell gene expression in liver-stem WB cells |
| Q48678243 | Penetratin peptide potentiates endogenous calcium-activated chloride currents in Xenopus oocytes |
| Q57594290 | Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway |
| Q40317625 | Penetratin-membrane association: W48/R52/W56 shield the peptide from the aqueous phase. |
| Q35080230 | Peptide and protein drug delivery to and into tumors: challenges and solutions |
| Q33754501 | Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides |
| Q59201770 | Peptide-Based Nanostructured Materials with Intrinsic Proapoptotic Activities in CXCR4+ Solid Tumors |
| Q88562771 | Peptide-Binding Nanoparticle Materials with Tailored Recognition sites for Basic Peptides |
| Q93138367 | Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases |
| Q37347451 | Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems |
| Q56889662 | Peptides as drug delivery vehicles across biological barriers |
| Q34489488 | Peptides displayed as high density brush polymers resist proteolysis and retain bioactivity |
| Q26746968 | Peptides for nucleic acid delivery |
| Q38027858 | Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery |
| Q38243361 | Peptides used in the delivery of small noncoding RNA. |
| Q48009486 | Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration |
| Q57360742 | Photo-acceleration of protein release from endosome in the protein transduction system |
| Q47602614 | Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates |
| Q40049879 | Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells. |
| Q42202499 | Plasma membrane translocation of a protein needle based on a triple-stranded β-helix motif |
| Q44563746 | Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpain |
| Q91975707 | Polyamide Backbone Modified Cell Targeting and Penetrating Peptides in Cancer Detection and Treatment |
| Q36004826 | Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing |
| Q37191389 | Polymeric linear Peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loading |
| Q50518471 | Potent enhancement of GFP uptake into HT‐29 cells and rat skin permeation by coincubation with tat peptide |
| Q28479013 | Prediction of Cell Penetrating Peptides by Support Vector Machines |
| Q53723317 | Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods. |
| Q38885454 | Preparation of cell-permeable Cre recombinase by expressed protein ligation |
| Q91891978 | Prevention of quality decline and delivery of siRNA using exogenous TCTP translocation across the zona pellucida in mouse oocytes |
| Q38785368 | Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide |
| Q50436669 | Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease |
| Q38205210 | Pros and cons of phospholipid asymmetry in erythrocytes |
| Q30410528 | Protein Structure Determination by Solid-State NMR |
| Q35345000 | Protein delivery using engineered virus-like particles |
| Q35136309 | Protein transduction domains: are they delivering? |
| Q45343688 | RETRACTED ARTICLE: Cell-specific delivery of messenger RNA and microRNA by recombinant MS2 virus-like particles carrying cell-penetrating peptide |
| Q34991955 | Rational design of a biomimetic cell penetrating peptide library |
| Q46637666 | Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1. |
| Q43918861 | Real time detection of cell cycle regulator cyclin A on living tumor cells with europium emission |
| Q27487857 | Recent Developments in Peptide-Based Nucleic Acid Delivery |
| Q36316659 | Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo |
| Q40603207 | Receptor/transporter-independent targeting of functional peptides across the plasma membrane |
| Q41008655 | Reconstitution of gene expression from a regulatory-protein-deficient hepatitis B virus genome by cell-permeable HBx protein |
| Q42176571 | Reducible, dibromomaleimide-linked polymers for gene delivery |
| Q34022618 | Reversible sheet-turn conformational change of a cell-penetrating peptide in lipid bilayers studied by solid-state NMR |
| Q44738584 | RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing |
| Q46008642 | Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication. |
| Q37297026 | Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR. |
| Q92211557 | SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery |
| Q33871187 | Scorpion venom components that affect ion-channels function |
| Q33938342 | Screening of a Combinatorial Homing Peptide Library for Selective Cellular Delivery |
| Q47244197 | Secondary structure of cell-penetrating peptides during interaction with fungal cells |
| Q41957814 | Secretion and uptake of TAT-fusion proteins produced by engineered mammalian cells |
| Q37430304 | Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials |
| Q33713342 | Selective enhancement of the uptake and bioactivity of a TAT-conjugated peptide inhibitor of glycogen synthase kinase-3. |
| Q38610657 | Self-aggregation propensity of the Tat peptide revealed by UV-Vis, NMR and MD analyses. |
| Q37237907 | Self-assembled Tat nanofibers as effective drug carrier and transporter. |
| Q40254465 | Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery |
| Q84137177 | Self‐Activation in De Novo Designed Mimics of Cell‐Penetrating Peptides |
| Q35705907 | Sensing pH via p-cyanophenylalanine fluorescence: Application to determine peptide pKa and membrane penetration kinetics |
| Q88472505 | Sequence-Selective Recognition of Peptides in Aqueous Solution: A Supramolecular Approach through Micellar Imprinting |
| Q38729047 | Short polyhistidine peptides penetrate effectively into Nicotiana tabacum-cultured cells and Saccharomyces cerevisiae cells |
| Q47117237 | Shortened Penetratin Cell-Penetrating Peptide Is Insufficient for Cytosolic Delivery of a Grb7 Targeting Peptide |
| Q90334868 | Silk Fibroin as a Functional Biomaterial for Drug and Gene Delivery |
| Q42595034 | Silk-Based Gene Carriers with Cell Membrane Destabilizing Peptides |
| Q37714025 | Silk-based delivery systems of bioactive molecules. |
| Q30541727 | Single quantum dot tracking reveals that an individual multivalent HIV-1 Tat protein transduction domain can activate machinery for lateral transport and endocytosis |
| Q55266626 | Single quantum dot tracking reveals the impact of nanoparticle surface on intracellular state. |
| Q44472217 | Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer |
| Q36436522 | Sizing the protein translocation pathway of colicin Ia channels |
| Q42809505 | Sono-assembly of highly biocompatible polysaccharide capsules for hydrophobic drug delivery |
| Q82324613 | Splice Redirection as a Convenient Assay to Monitor CPP–ON Efficiency and Mechanism |
| Q47762139 | Spontaneous Membrane Translocating Peptides: The Role of Leucine-Arginine Consensus Motifs |
| Q46697816 | Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties. |
| Q51769861 | Stable and sensitive probes for lysosomes: cell-penetrating fluorescent calix[4]arenes accumulate in acidic vesicles |
| Q39347424 | Structural Effects and Lipid Membrane Interactions of the pH-Responsive GALA Peptide with Fatty Acid Acylation |
| Q27300105 | Structural and functional studies of a phosphatidic acid-binding antifungal plant defensin MtDef4: identification of an RGFRRR motif governing fungal cell entry |
| Q33827462 | Structure and dynamics of cationic membrane peptides and proteins: insights from solid-state NMR. |
| Q39315664 | Structure-function relationship of the nuclear localization signal sequence of parathyroid hormone-related protein |
| Q44463875 | Studies on the internalization mechanism of cationic cell-penetrating peptides. |
| Q39750541 | Study on the intracellular fate of Tat peptide-conjugated quantum dots by spectroscopic investigation |
| Q59662712 | Studying the uptake of cell-penetrating peptides |
| Q38289633 | Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells |
| Q30489569 | Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. |
| Q51362699 | Synergistic Anticancer Effect of Peptide-Docetaxel Nanoassembly Targeted to Tubulin: Toward Development of Dual Warhead Containing Nanomedicine |
| Q42269919 | Synthesis and Splice-Redirecting Activity of Branched, Arginine-Rich Peptide Dendrimer Conjugates of Peptide Nucleic Acid Oligonucleotides |
| Q81584715 | Synthesis and biophysical characterization of stabilized alpha-helices of BCL-2 domains |
| Q83417203 | Synthesis of N-methylated cyclic peptides |
| Q24793327 | Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides |
| Q39373677 | Synthetic Nucleic Acid Analogues in Gene Therapy: An Update for Peptide-Oligonucleotide Conjugates |
| Q34545352 | Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers |
| Q39761178 | Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides |
| Q39316870 | TAT-CC fusion protein depresses the oncogenicity of BCR-ABL in vitro and in vivo through interrupting its oligomerization |
| Q39850094 | TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression |
| Q35818922 | TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability. |
| Q34267418 | Target discovery |
| Q58566968 | Targeted Intracellular Delivery of Antibodies: The State of the Art |
| Q39116826 | Targeted delivery of a phosphopeptide prodrug inhibits the proliferation of a human glioma cell line |
| Q37682695 | Targeted delivery of ubiquitin-conjugated BH3 peptide-based Mcl-1 inhibitors into cancer cells |
| Q73556234 | Targeted drug delivery systems for the intracellular delivery of macromolecular drugs |
| Q61444841 | Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14 |
| Q35057544 | Targeted intracellular delivery of proteins with spatial and temporal control |
| Q33865968 | Targeting a ruthenium complex to the nucleus with short peptides |
| Q37368323 | Targeting anti-HIV drugs to the CNS. |
| Q37811739 | Targeting antibodies to the cytoplasm |
| Q38017804 | Targeting drugs to mitochondria |
| Q35826370 | Targeting plasmid-encoded proteins to the antigen presentation pathways |
| Q44624372 | Targeting proteins to mitochondria using TAT. |
| Q26799461 | Targeting the Eph System with Peptides and Peptide Conjugates |
| Q38974209 | Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy. |
| Q40027318 | Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease. |
| Q34054988 | Tat-Mediated Peptide Intervention in Analgesia and Anesthesia. |
| Q46934430 | Tat-mediated protein transduction of human brain pyridoxine-5-P oxidase into PC12 cells |
| Q41849682 | Taurine Boosts Cellular Uptake of Small D-Peptides for Enzyme-Instructed Intracellular Molecular Self-Assembly |
| Q40184296 | Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells. |
| Q35211115 | Tempo-spatially resolved cellular dynamics of human immunodeficiency virus transacting activator of transcription (Tat) peptide-modified nanocargos in living cells |
| Q38552370 | The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides. |
| Q83259815 | The Effects of the 4‐(4‐Methylpiperazine)phenyl Group on Nucleosides and Oligonucleotides: Cellular Delivery, Detection, and Stability |
| Q40478564 | The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. |
| Q48761244 | The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP–protein cargos to the cytosol of eukaryotic cells |
| Q40666814 | The Relation Between Thermodynamic and Structural Properties and Cellular Uptake of Peptides Containing Tryptophan and Arginine. |
| Q47743746 | The Role of Hydrophobicity in the Cellular Uptake of Negatively Charged Macromolecules. |
| Q92825203 | The Utilization of Cell-Penetrating Peptides in the Intracellular Delivery of Viral Nanoparticles |
| Q30159968 | The anti-angiogenic peptide anginex disrupts the cell membrane |
| Q45869894 | The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes |
| Q39544225 | The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH |
| Q57187330 | The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes |
| Q39395281 | The cell-penetrating peptide domain from human heparin-binding epidermal growth factor-like growth factor (HB-EGF) has anti-inflammatory activity in vitro and in vivo |
| Q35950928 | The design and exogenous delivery of siRNA for post-transcriptional gene silencing. |
| Q37047226 | The design of guanidinium-rich transporters and their internalization mechanisms. |
| Q49627191 | The design of peptide-grafted graphene oxide targeting the actin cytoskeleton for efficient cancer therapy. |
| Q49611544 | The development of ruthenium(ii) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications. |
| Q46236828 | The effect of cell penetrating peptides on transfection activity and cytotoxicity of polyallylamine |
| Q34277312 | The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate |
| Q35562110 | The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding |
| Q88394411 | The mechanism of lauric acid-modified protein nanocapsules escape from intercellular trafficking vesicles and its implication for drug delivery |
| Q36270676 | The role of ganglioside GM1 in cellular internalization mechanisms of poly(amidoamine) dendrimers. |
| Q33937098 | The short splice variant of the gamma 2 subunit acts as an external modulator of GABA(A) receptor function |
| Q44301552 | The signal peptide NPFSD fused to ricin A chain enhances cell uptake and cytotoxicity in Candida albicans |
| Q40532537 | The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells |
| Q36695464 | The taming of the cell penetrating domain of the HIV Tat: myths and realities |
| Q35969026 | The use of cell-penetrating peptides for drug delivery |
| Q33268306 | The use of fullerene substituted phenylalanine amino acid as a passport for peptides through cell membranes |
| Q39541679 | The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells |
| Q38104407 | Therapeutic potential of cell-penetrating peptides. |
| Q43842753 | Thermodynamics of Lipid Interactions with Cell-Penetrating Peptides |
| Q36911058 | Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8. |
| Q45876050 | Topical application of the antiapoptotic TAT-FNK protein prevents aminoglycoside-induced ototoxicity |
| Q36409033 | Transactivating transcriptional activator-mediated drug delivery |
| Q34311057 | Transactivating-transduction protein-polyethylene glycol modified liposomes traverse the blood-spinal cord and blood-brain barriers |
| Q53432656 | Transduced PEP-1-FK506BP Ameliorates Atopic Dermatitis in NC/Nga Mice |
| Q46750570 | Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult |
| Q50572161 | Transduction of cell-penetrating peptides into induced pluripotent stem cells. |
| Q42807094 | Transduction of peptides and proteins into live cells by cell penetrating peptides |
| Q33496608 | Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathway |
| Q42781312 | Transfer of arginine into lipid bilayers is nonadditive. |
| Q35939416 | Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells. |
| Q33510861 | Translocation and endocytosis for cell-penetrating peptide internalization |
| Q35345277 | Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions |
| Q44597076 | Translocation of cell penetrating peptides on Chlamydomonas reinhardtii |
| Q46359263 | Translocation of cell-penetrating peptides into Candida fungal pathogens |
| Q34419039 | Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission |
| Q37530890 | Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225). |
| Q92434851 | Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization |
| Q24796110 | Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide |
| Q40461207 | Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA. |
| Q33569121 | Tumor imaging by means of proteolytic activation of cell-penetrating peptides |
| Q37230918 | Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics |
| Q39290246 | Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy |
| Q28511917 | Unique membrane interaction mode of group IIF phospholipase A2 |
| Q50021294 | Uptake and intracellular fate of cholera toxin subunit b-modified mesoporous silica nanoparticle-supported lipid bilayers (aka protocells) in motoneurons |
| Q30728924 | Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells |
| Q51361449 | Use of quantum dots for live cell imaging |
| Q50776745 | VP22 enhances antibody responses from DNA vaccines but not by intercellular spread |
| Q38872440 | Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells |
| Q37657525 | Various drug delivery approaches to the central nervous system |
| Q38195650 | Vectorology and factor delivery in induced pluripotent stem cell reprogramming. |
| Q46783979 | Vesicular disruption of lysosomal targeting organometallic polyarginine bioconjugates |
| Q42866635 | Visualization of Amyloid Formation Processes on Cell Membranes: Gangliosides as Key Molecules for the Onset of Amyloidosis |
| Q42726492 | Visualizing Gold Nanoparticle Uptake in Live Cells with Liquid Scanning Transmission Electron Microscopy |
| Q92824512 | pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications |
| Q38043064 | siRNA Delivery: From Lipids to Cell‐penetrating Peptides and Their Mimics |
Search more.